Liaoning Chengda Biotechnology Co. Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Liaoning Chengda Biotechnology Co. Ltd.

Why is Liaoning Chengda Biotechnology Co. Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -4.96% and Operating profit at -31.15% over the last 5 years

With a fall in Net Sales of -7.79%, the company declared Very Negative results in Sep 25

The company has declared negative results for the last 2 consecutive quarters
NET SALES(HY) At CNY 737.49 MM has Grown at -21.37%
OPERATING CASH FLOW(Y) Lowest at CNY 409.18 MM
PRE-TAX PROFIT(Q) At CNY 64.52 MM has Fallen at -54.67%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -10.09% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Liaoning Chengda Biotechnology Co. Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Liaoning Chengda Biotechnology Co. Ltd.

-10.33%

-0.17

18.13%

China Shanghai Composite

16.67%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-4.96%

EBIT Growth (5y)

-31.15%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.56

Sales to Capital Employed (avg)

0.18

Tax Ratio

10.80%

Dividend Payout Ratio

96.39%

Pledged Shares

Institutional Holding

ROCE (avg)

23,213.24%

ROE (avg)

16,776.56%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.20

EV to EBIT

29.05

EV to EBITDA

15.78

EV to Capital Employed

1.45

EV to Sales

4.15

PEG Ratio

Dividend Yield

1.27%

ROCE (Latest)

4.99%

ROE (Latest)

2.87%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -7.48% (YoY

-28What is not working for the Company

NET SALES(HY)

At CNY 737.49 MM has Grown at -21.37%

OPERATING CASH FLOW(Y)

Lowest at CNY 409.18 MM

PRE-TAX PROFIT(Q)

At CNY 64.52 MM has Fallen at -54.67%

NET PROFIT(Q)

At CNY 41.71 MM has Fallen at -63.29%

ROCE(HY)

Lowest at 1.88%

DEBT-EQUITY RATIO (HY)

Highest at -53.88 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 1.24 times

Here's what is working for Liaoning Chengda Biotechnology Co. Ltd.

Raw Material Cost

Fallen by -7.48% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Liaoning Chengda Biotechnology Co. Ltd.

Net Sales

At CNY 737.49 MM has Grown at -21.37%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (CNY MM)

Pre-Tax Profit

At CNY 64.52 MM has Fallen at -54.67%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 41.71 MM has Fallen at -63.29%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow

Lowest at CNY 409.18 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Debt-Equity Ratio

Highest at -53.88 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio

Lowest at 1.24 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio